TEVA logo

TEVA Long Term Liabilities

Annual Total Long Term Liabilities

$20.81 B
-$2.30 B-9.94%

December 31, 2024


Summary


Performance

TEVA Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTEVAbalance sheetmetrics:

Quarterly Long Term Liabilities

$20.81 B
-$767.00 M-3.55%

December 31, 2024


Summary


Performance

TEVA Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTEVAbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

TEVA Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-9.9%-2.9%
3 y3 years-18.1%-17.1%
5 y5 years-27.6%-21.2%

TEVA Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.1%at low-18.1%at low
5 y5-year-27.6%at low-27.6%at low
alltimeall time-47.4%>+9999.0%-51.0%>+9999.0%

Teva Pharmaceutical Industries Limited Long Term Liabilities History

DateAnnualQuarterly
Dec 2024
$20.81 B(-9.9%)
$20.81 B(-3.6%)
Sep 2024
-
$21.58 B(-0.7%)
Jun 2024
-
$21.74 B(+1.4%)
Mar 2024
-
$21.44 B(-7.2%)
Dec 2023
$23.11 B(-3.5%)
$23.11 B(-0.3%)
Sep 2023
-
$23.18 B(-1.5%)
Jun 2023
-
$23.54 B(-3.6%)
Mar 2023
-
$24.43 B(+2.0%)
Dec 2022
$23.94 B(-5.7%)
$23.94 B(+3.2%)
Sep 2022
-
$23.20 B(-7.6%)
Jun 2022
-
$25.11 B(-0.3%)
Mar 2022
-
$25.19 B(-0.8%)
Dec 2021
$25.39 B(-3.9%)
$25.39 B(+3.3%)
Sep 2021
-
$24.57 B(-2.5%)
Jun 2021
-
$25.19 B(-2.9%)
Mar 2021
-
$25.94 B(-1.8%)
Dec 2020
$26.41 B(-8.1%)
$26.41 B(-2.3%)
Sep 2020
-
$27.04 B(-4.8%)
Jun 2020
-
$28.42 B(-0.0%)
Mar 2020
-
$28.42 B(-1.1%)
Dec 2019
$28.73 B(-6.0%)
$28.73 B(+1.8%)
Sep 2019
-
$28.21 B(-5.1%)
Jun 2019
-
$29.72 B(-0.9%)
Mar 2019
-
$30.00 B(-1.8%)
Dec 2018
$30.57 B(-10.0%)
$30.57 B(-1.7%)
Sep 2018
-
$31.10 B(-7.0%)
Jun 2018
-
$33.45 B(-2.6%)
Mar 2018
-
$34.32 B(+1.1%)
Dec 2017
$33.95 B(-14.2%)
$33.95 B(-12.6%)
Sep 2017
-
$38.84 B(-5.9%)
Jun 2017
-
$41.29 B(+4.2%)
Mar 2017
-
$39.63 B(+0.1%)
Dec 2016
$39.58 B(+250.2%)
$39.58 B(-6.7%)
Sep 2016
-
$42.43 B(+269.4%)
Jun 2016
-
$11.49 B(-1.2%)
Mar 2016
-
$11.63 B(+2.9%)
Dec 2015
$11.30 B(+4.9%)
$11.30 B(-11.3%)
Sep 2015
-
$12.75 B(-0.5%)
Jun 2015
-
$12.81 B(+8.5%)
Mar 2015
-
$11.81 B(+9.6%)
Dec 2014
$10.78 B(-16.5%)
$10.78 B(-4.4%)
Sep 2014
-
$11.27 B(-0.2%)
Jun 2014
-
$11.29 B(-9.4%)
Mar 2014
-
$12.46 B(-3.5%)
Dec 2013
$12.91 B(-13.1%)
$12.91 B(-3.0%)
Sep 2013
-
$13.30 B(+1.9%)
Jun 2013
-
$13.06 B(+1.2%)
Mar 2013
-
$12.90 B(-13.2%)
Dec 2012
$14.85 B(+5.2%)
$14.85 B(-6.5%)
Sep 2012
-
$15.88 B(-0.6%)
Jun 2012
-
$15.98 B(+17.2%)
Mar 2012
-
$13.64 B(-3.4%)
Dec 2011
$14.12 B(+118.8%)
$14.12 B(+105.9%)
Sep 2011
-
$6.86 B(+7.8%)
Jun 2011
-
$6.36 B(-12.1%)
Mar 2011
-
$7.24 B(+12.1%)
Dec 2010
$6.46 B(+0.1%)
$6.46 B(-19.4%)
Sep 2010
-
$8.01 B(+4.8%)
Jun 2010
-
$7.64 B(+26.8%)
Mar 2010
-
$6.03 B(-6.6%)
DateAnnualQuarterly
Dec 2009
$6.45 B(-20.0%)
$6.45 B(-4.6%)
Sep 2009
-
$6.76 B(-5.6%)
Jun 2009
-
$7.16 B(-5.0%)
Mar 2009
-
$7.54 B(-6.5%)
Dec 2008
$8.06 B(+88.3%)
$8.06 B(+57.9%)
Sep 2008
-
$5.11 B(+14.9%)
Jun 2008
-
$4.45 B(0.0%)
Mar 2008
-
$4.45 B(+3.9%)
Dec 2007
$4.28 B(-18.0%)
$4.28 B(-0.9%)
Sep 2007
-
$4.32 B(-12.1%)
Jun 2007
-
$4.91 B(-1.0%)
Mar 2007
-
$4.96 B(-5.0%)
Dec 2006
$5.22 B(+151.5%)
$5.22 B(-4.1%)
Sep 2006
-
$5.45 B(+0.1%)
Jun 2006
-
$5.44 B(-0.0%)
Mar 2006
-
$5.44 B(+162.0%)
Dec 2005
$2.08 B(+2.4%)
$2.08 B(+8.0%)
Sep 2005
-
$1.92 B(-5.1%)
Jun 2005
-
$2.03 B(+0.3%)
Mar 2005
-
$2.02 B(-0.4%)
Dec 2004
$2.03 B(+119.3%)
$2.03 B(+0.1%)
Sep 2004
-
$2.02 B(-6.7%)
Jun 2004
-
$2.17 B(-1.6%)
Mar 2004
-
$2.21 B(+138.6%)
Dec 2003
$924.90 M(-27.1%)
$924.90 M(+0.8%)
Sep 2003
-
$917.50 M(-29.0%)
Jun 2003
-
$1.29 B(+2.0%)
Mar 2003
-
$1.27 B(-0.2%)
Dec 2002
$1.27 B(-5.3%)
$1.27 B(-7.2%)
Sep 2002
-
$1.37 B(-0.8%)
Jun 2002
-
$1.38 B(+2.1%)
Mar 2002
-
$1.35 B(+0.8%)
Dec 2001
$1.34 B(+45.7%)
$1.34 B(-0.1%)
Sep 2001
-
$1.34 B(+50.8%)
Jun 2001
-
$889.41 M(-2.7%)
Mar 2001
-
$913.68 M(-0.6%)
Dec 2000
$918.88 M(+98.3%)
$918.88 M(+76.0%)
Sep 2000
-
$522.00 M(+27.8%)
Jun 2000
-
$408.40 M(-4.7%)
Mar 2000
-
$428.68 M(-7.5%)
Dec 1999
$463.46 M(+94.1%)
$463.46 M(+32.5%)
Sep 1999
-
$349.90 M(+41.3%)
Jun 1999
-
$247.70 M(+4.8%)
Mar 1999
-
$236.40 M(-1.0%)
Dec 1998
$238.80 M(+61.4%)
$238.80 M(+9.5%)
Sep 1998
-
$218.00 M(+1.1%)
Jun 1998
-
$215.70 M(+65.8%)
Mar 1998
-
$130.10 M(-12.1%)
Dec 1997
$148.00 M(-19.8%)
$148.00 M(-19.8%)
Dec 1996
$184.50 M(+62.6%)
$184.50 M(+62.6%)
Dec 1995
$113.50 M(+21.0%)
$113.50 M(+21.0%)
Dec 1994
$93.80 M(+11.1%)
$93.80 M(+11.1%)
Dec 1993
$84.40 M(+62.0%)
$84.40 M(+62.0%)
Dec 1992
$52.10 M(-26.3%)
$52.10 M(-26.3%)
Dec 1991
$70.70 M(-22.8%)
$70.70 M(-22.8%)
Dec 1990
$91.60 M(+6.4%)
$91.60 M(+6.4%)
Dec 1989
$86.10 M(+47.4%)
$86.10 M(+47.4%)
Dec 1988
$58.40 M(+50.1%)
$58.40 M(+50.1%)
Mar 1987
$38.90 M(-14.7%)
$38.90 M(-14.7%)
Mar 1986
$45.60 M
$45.60 M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual total long term liabilities year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly long term liabilities year-on-year change?

What is Teva Pharmaceutical Industries Limited annual total long term liabilities?

The current annual total long term liabilities of TEVA is $20.81 B

What is the all time high annual total long term liabilities for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual total long term liabilities is $39.58 B

What is Teva Pharmaceutical Industries Limited annual total long term liabilities year-on-year change?

Over the past year, TEVA annual total long term liabilities has changed by -$2.30 B (-9.94%)

What is Teva Pharmaceutical Industries Limited quarterly total long term liabilities?

The current quarterly long term liabilities of TEVA is $20.81 B

What is the all time high quarterly long term liabilities for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly total long term liabilities is $42.43 B

What is Teva Pharmaceutical Industries Limited quarterly long term liabilities year-on-year change?

Over the past year, TEVA quarterly total long term liabilities has changed by -$628.00 M (-2.93%)